| P2093 | author name string | Ernst E | |
| P2860 | cites work | Does blood rheology revert to normal after myocardial infarction? | Q33610605 |
| | Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study | Q33612289 |
| | Does weight loss reduce plasma fibrinogen? | Q33613250 |
| | Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. | Q35168292 |
| | Influence of smoking and plasma factors on patency of femoropopliteal vein grafts | Q35716459 |
| | Oral contraceptives, fibrinogen and cardiovascular risk | Q36166292 |
| | The effect of age on the fibrinolytic enzyme system | Q36659895 |
| | Plasma fibrinogen--an independent cardiovascular risk factor | Q37930696 |
| | Atherosclerosis and the coagulation system | Q38713518 |
| | The normal and morbid biology of fibrinogen | Q38720376 |
| | Is increased plasma viscosity a risk factor for high blood pressure? | Q39285854 |
| | Haematological stress syndrome in atherosclerosis | Q39338214 |
| | Plasma-fibrinogen and thromboemboli after myocardial infarction | Q39409521 |
| | Leukocytes and the risk of ischemic diseases | Q39765300 |
| | Hemorrheologic changes following acute myocardial infarction | Q40105120 |
| | High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. | Q41110151 |
| | White blood cell count and cardiovascular disease. Insights from the Framingham Study | Q41121224 |
| | Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study | Q41206667 |
| | Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study | Q41300471 |
| | Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys | Q41830774 |
| | Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations | Q41887737 |
| | Influence of platelet size on outcome after myocardial infarction | Q43705998 |
| | Haemostatic measures in type 2 diabetic patients with microalbuminuria | Q43737649 |
| | Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 |
| | Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years | Q44132801 |
| | Seasonal variations in fibrinogen concentrations among elderly people | Q44760478 |
| | Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience | Q44776229 |
| | Genetic and cultural inheritance of plasma fibrinogen concentration | Q47391741 |
| | Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors | Q48434703 |
| | Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. | Q50289871 |
| | Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 |
| | Relation between extent of coronary artery disease and blood viscosity. | Q54965703 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15-22 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Fibrinogen: an important risk factor for atherothrombotic diseases | |
| P478 | volume | 26 | |